KoBioLabs, Inc

KOSDAQ:A348150 Stock Report

Market Cap: ₩99.8b

KoBioLabs Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

GwangPyo Ko

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.9yrs
CEO ownership29.8%
Management average tenure2.9yrs
Board average tenureno data

Recent management updates

No updates

Recent updates

Take Care Before Diving Into The Deep End On KoBioLabs, Inc (KOSDAQ:348150)

Nov 13
Take Care Before Diving Into The Deep End On KoBioLabs, Inc (KOSDAQ:348150)

Does KoBioLabs (KOSDAQ:348150) Have A Healthy Balance Sheet?

Sep 06
Does KoBioLabs (KOSDAQ:348150) Have A Healthy Balance Sheet?

Cautious Investors Not Rewarding KoBioLabs, Inc's (KOSDAQ:348150) Performance Completely

Jul 12
Cautious Investors Not Rewarding KoBioLabs, Inc's (KOSDAQ:348150) Performance Completely

We're Not Worried About KoBioLabsInc's (KOSDAQ:348150) Cash Burn

Apr 15
We're Not Worried About KoBioLabsInc's (KOSDAQ:348150) Cash Burn

What Type Of Shareholders Own The Most Number of KoBioLabs,Inc (KOSDAQ:348150) Shares?

Feb 18
What Type Of Shareholders Own The Most Number of KoBioLabs,Inc (KOSDAQ:348150) Shares?

CEO

GwangPyo Ko

2.9yrs

Tenure

Mr. GwangPyo Ko, Sc.D. serves as Founder and Chief Executive Officer at KoBioLabs,Inc. He began his career as a microbiologist, working in research for a number of years before finding a Kobiolabs. He has...

Leadership Team

NamePositionTenureCompensationOwnership
GwangPyo Ko
Founder & CEO2.9yrsno data29.76%
₩ 29.7b
Hyunkyu Lim
Chief Finance Officer1.9yrsno datano data
Han Seung Lee
Chief Operating Officer1.9yrsno datano data
Sang Lim
Chief Technology Officerno datano datano data
Yong Won Shin
Head of CMC Departmentno datano datano data
Hyungjin Lee
Chief Strategy Officer3.9yrsno datano data
Yurn-Su Song
Head of Clinical Developmentno datano datano data
Hyun Ju You
Head of Microbiome Center2.9yrsno datano data
Sangmi Nam
Head of Business Department2.9yrsno datano data

2.9yrs

Average Tenure

Experienced Management: A348150's management team is considered experienced (2.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 07:06
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

KoBioLabs, Inc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution